XML 23 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 578,626 $ 48,199
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 425,582 369,629
Amortization of market lease intangibles, net (1,393) (980)
Amortization of deferred compensation 19,307 21,068
Amortization of deferred financing costs 15,598 14,950
Straight-line rents (14,412) (24,817)
Loan and direct financing lease non-cash interest 385 (71,243)
Deferred rental revenues (1,027) (1,496)
Equity loss (income) from unconsolidated joint ventures 4,028 (33,916)
Distributions of earnings from unconsolidated joint ventures 5,919 4,587
Lease termination income, net   (1,103)
Gain on sales of real estate (119,605) (6,377)
Deferred income tax expense 47,195  
Foreign exchange and other gains, net (127) (7,103)
Impairment   620,155
Changes in:    
Accounts receivable, net 7,558 (10,634)
Other assets, net (9,674) (1,186)
Accounts payable and other accrued liabilities 40,672 (52,073)
Net cash provided by operating activities 998,632 867,660
Cash flows from investing activities:    
Acquisitions of real estate (257,242) (1,200,661)
Development of real estate (304,818) (190,082)
Leasing costs and tenant and capital improvements (64,501) (52,371)
Proceeds from sales of real estate, net 211,810 19,555
Contributions to unconsolidated joint ventures (10,169) (43,242)
Distributions in excess of earnings from unconsolidated joint ventures 14,458 16,086
Proceeds from sales of marketable securities   782
Principal repayments on loans receivable, direct financing leases and other 221,179 51,491
Investments in loans receivable and other (129,335) (283,252)
Decrease (increase) in restricted cash 4,459 (3,891)
Net cash used in investing activities (314,159) (1,685,585)
Cash flows from financing activities:    
Net borrowings under bank line of credit 1,157,897 282,099
Repayments under bank line of credit (135,000) (102,063)
Borrowings under term loan   333,014
Issuance of senior unsecured notes   1,338,555
Repayments of senior unsecured notes (900,000) (400,000)
Repayments of mortgage and other debt (249,540) (50,187)
Deferred financing costs (1,057) (14,556)
Issuance of common stock and exercise of options 59,184 169,497
Repurchase of common stock (8,667) (8,006)
Dividends paid on common stock (806,243) (783,578)
Issuance of noncontrolling interests 4,785 4,812
Distributions to noncontrolling interest (18,687) (13,707)
Net cash (used in) provided by financing activities (897,328) 755,880
Effect of foreign exchange on cash and cash equivalents (754) (1,267)
Net decrease in cash and cash equivalents (213,609) (63,312)
Cash and cash equivalents, beginning of year 346,500 183,810
Cash and cash equivalents, end of year $ 132,891 $ 120,498